At a recent event organized by that consortium, the New Jersey Alliance for Clinical and Translational Science(NJACTS), leaders from academia, healthcare, government and the pharmaceutical industry discussed the future of scientific and clinical trial innovation in the state. These new innovations will result from a $33-million grant from the National Institutes of Health (NIH). To read the full story.
- New NJACTS Publication
- COLUMN: Medicine must ‘widen the doors’ to people of color
- Rutgers to Expand Entrepreneurship Training Programs for Researchers as Partner in New NSF I-Corps™ Hub: Northeast Region.
- Need Amid Plenty: Richest US Counties Are Overwhelmed by Surge in Child Hunger
- How to live with the Delta mutant, according to disease experts – NFL Sports.